XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
GENERAL (Details) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Aug. 05, 2013
Jan. 31, 2024
Mar. 30, 2018
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 18, 2023
Nov. 10, 2021
Oct. 10, 2018
GENERAL [Abstract]                  
Net loss       $ 9,390 $ 18,615        
Accumulated deficit       483,917   $ 474,527      
Net cash used in operating activities       $ 39,703 $ (18,573)        
Upfront payment received $ 10,000   $ 10,000            
Preclinical milestone compensation $ 23,000                
Accrued milestone payment     30,500            
Potential milestone compensation     $ 200,000            
Amount of investment in Compugen               $ 20,000 $ 12,000
Non-refundable upfront payment   $ 60,000              
Milestone payment   $ 30,000              
Potential milestone compensation company is now eligible for             $ 758,000    
Percentage of expected from upfront payment amount paid   15.00%